HM Payson & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q3 | $137M | Sell |
|
|||||
2025
Q2 | $111M | Sell |
|
|||||
2025
Q1 | $128M | Sell |
|
|||||
2024
Q4 | $109M | Buy |
|
|||||
2024
Q3 | $114M | Buy |
|
|||||
2024
Q2 | $97.7M | Buy |
|
|||||
2024
Q1 | $104M | Buy |
|
|||||
2023
Q4 | $88.1M | Buy |
|
|||||
2023
Q3 | $81M | Buy |
|
|||||
2023
Q2 | $72.4M | Buy |
|
|||||
2023
Q1 | $83.6M | Buy |
|
|||||
2022
Q4 | $83.1M | Buy |
|
|||||
2022
Q3 | $67.6M | Buy |
|
|||||
2022
Q2 | $75.3M | Sell |
|
|||||
2022
Q1 | $80.7M | Buy |
|
|||||
2021
Q4 | $64.9M | Sell |
|
|||||
2021
Q3 | $54.4M | Sell |
|
|||||
2021
Q2 | $58.5M | Buy |
|
|||||
2021
Q1 | $53.1M | Buy |
|
|||||
2020
Q4 | $52.4M | Sell |
|
|||||
2020
Q3 | $44.5M | Buy |
|
|||||
2020
Q2 | $35.5M | Buy |
|
|||||
2020
Q1 | $27.1M | Buy |
|
|||||
2019
Q4 | $30.3M | Sell |
|
|||||
2019
Q3 | $26.1M | Sell |
|
|||||
2019
Q2 | $26.2M | Buy |
|
|||||
2019
Q1 | $29M | Buy |
|
|||||
2018
Q4 | $72K | Sell |
|
|||||
2018
Q3 | $30.4M | Sell |
|
|||||
2018
Q2 | $31.9M | Buy |
|
|||||
2018
Q1 | $32.2M | Buy |
|
|||||
2017
Q4 | $32.9M | Buy |
|
|||||
2017
Q3 | $24.5M | Sell |
|
|||||
2017
Q2 | $20M | Buy |
|
|||||
2017
Q1 | $17.6M | Buy |
|
|||||
2016
Q4 | $16.8M | Sell |
|
|||||
2016
Q3 | $17M | Sell |
|
|||||
2016
Q2 | $16.9M | Sell |
|
|||||
2016
Q1 | $16.2M | Buy |
|
|||||
2015
Q4 | $16.3M | Buy |
|
|||||
2015
Q3 | $14.3M | Sell |
|
|||||
2015
Q2 | $19.6M | Sell |
|
|||||
2015
Q1 | $17.3M | Sell |
|
|||||
2014
Q4 | $20.4M | Sell |
|
|||||
2014
Q3 | $18.7M | Sell |
|
|||||
2014
Q2 | $19.7M | Sell |
|
|||||
2014
Q1 | $18.5M | Sell |
|
|||||
2013
Q4 | $21.2M | Sell |
|
|||||
2013
Q3 | $18.3M | Sell |
|
|||||
2013
Q2 | $17.4M | Buy |
|